Bupropion Hydrochloride
- Product NDC
- 68001-322
- 11-digit product format
- 680010322
- Labeler code
- 68001
- Product ID
- 68001-322_e1e1a0e3-d82a-0669-e053-2a95a90a21cb
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- bupropion hydrochloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- BluePoint Laboratories
- Application
- ANDA206556
- Marketing category
- ANDA
- Marketing start
- 2017-03-22
- Marketing end
- 2022-11-30
- Substance
- BUPROPION HYDROCHLORIDE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68001-322-03 | 68001032203 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (68001-322-03) | 2017-03-22 | 0000-00-00 | No | No | Current |
| 68001-322-04 | 68001032204 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (68001-322-04) | 2017-03-22 | 0000-00-00 | No | No | Current |
| 68001-322-05 | 68001032205 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (68001-322-05) | 2017-03-22 | 0000-00-00 | No | No | Current |